To gain an understanding of the association of ALDH1A1 gene expression with AML risk group classification and patient survival, we took into consideration nine independent datasets that were derived from six clinical studies of AML, which enrolled a total of over 1000 patients. This evidence concerns the gene ALDH1A1 and acute myeloid leukemia.